---
figid: PMC7963155__cancers-13-01168-g004a
figlink: .na.character
number: F4a
caption: miRNA-lncRNAs regulatory loops determine cisplatin resistance in cervical
  cancer. In cisplatin-sensitive cells (blue rectangles) GAS5 or CASC2 lncRNAs sponge
  miR-21, thus PTEN dephosphorylates PIP3 into PI2, preventing AKT pathway activation,
  resulting in reduced proliferation, drug resistance, and increased cell apoptosis
  (A). In resistant cells (red rectangle), the downregulation of GAS5 and CASC2 cause
  the PTEN inhibition by miR-21 determining the PI3K/AKT pathway activation (B). MiR-21
  can also contribute to the repression of the two lncRNAs (A,B). In cisplatin-resistant
  cells (red rectangle), the sponging of miR-134-5p by NCK1-AS1 leads to MSH2, ABCB1,
  and Bcl-2 up-regulation determining drug resistance and cell survival (D). In cisplatin-sensitive
  cells (blue rectangle), the downregulation of the lncRNA NCK1-AS1 determines the
  inhibition of MSH2 by miR-134-5p, associated with a decrease of ABCB1 and Bcl-2
  to promote cisplatin-induced cell death (C).
pmcid: PMC7963155
papertitle: The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical
  Cancer.
reftext: Rina Masadah, et al. Cancers (Basel). 2021 Mar;13(5):1168.
pmc_ranked_result_index: '1853'
pathway_score: 0.9690643
filename: cancers-13-01168-g004a.jpg
figtitle: MicroRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7963155__cancers-13-01168-g004a.html
  '@type': Dataset
  description: miRNA-lncRNAs regulatory loops determine cisplatin resistance in cervical
    cancer. In cisplatin-sensitive cells (blue rectangles) GAS5 or CASC2 lncRNAs sponge
    miR-21, thus PTEN dephosphorylates PIP3 into PI2, preventing AKT pathway activation,
    resulting in reduced proliferation, drug resistance, and increased cell apoptosis
    (A). In resistant cells (red rectangle), the downregulation of GAS5 and CASC2
    cause the PTEN inhibition by miR-21 determining the PI3K/AKT pathway activation
    (B). MiR-21 can also contribute to the repression of the two lncRNAs (A,B). In
    cisplatin-resistant cells (red rectangle), the sponging of miR-134-5p by NCK1-AS1
    leads to MSH2, ABCB1, and Bcl-2 up-regulation determining drug resistance and
    cell survival (D). In cisplatin-sensitive cells (blue rectangle), the downregulation
    of the lncRNA NCK1-AS1 determines the inhibition of MSH2 by miR-134-5p, associated
    with a decrease of ABCB1 and Bcl-2 to promote cisplatin-induced cell death (C).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PTEN
  - PLP2
  - AKT2
  - AKT3
  - AKT1
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - Cisplatin
  - cancer
genes:
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PIP2
  symbol: PLP2
  source: hgnc_symbol
  hgnc_symbol: PLP2
  entrez: '5355'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PIP2
  symbol: PLP2
  source: hgnc_symbol
  hgnc_symbol: PLP2
  entrez: '5355'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
chemicals:
- word: Cisplatin
  source: MESH
  identifier: D002945
diseases:
- word: cancer
  source: MESH
  identifier: D009369
figid_alias: PMC7963155__F4a
redirect_from: /figures/PMC7963155__F4a
figtype: Figure
---
